Britain city Sanofi covid-19 pandemic vaccine Government Britain city Sanofi

Sanofi and GSK to supply Covid-19 vaccine doses to UK

Reading now: 389
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Sanofi and GlaxoSmithKline (GSK) have signed an agreement with the UK Government to supply up to 60 million doses of a potential Covid-19 vaccine.

The vaccine is based on Sanofi’s recombinant protein-based technology, used to produce an influenza vaccine, as well as GSK’s pandemic adjuvant technology.

Sanofi is responsible for the clinical development and registration of the vaccine. The company expects to begin a Phase I / II clinical trial in September, followed by a Phase III trial by the end of the year.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA